-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
eFFECTOR Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2021 to Q1 2024.
- eFFECTOR Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $14.2M, a 6613% increase year-over-year.
- eFFECTOR Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $21.2M, a 668% increase from 2022.
- eFFECTOR Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2.77M, a 95.3% decline from 2021.
- eFFECTOR Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $58.8M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)